BerandaSHTDY • OTCMKTS
add
Sinopharm Group ADR
Tutup sebelumnya
$12,67
Rentang hari
$12,82 - $12,95
Rentang tahun
$10,13 - $16,31
Kapitalisasi pasar
63,07 M HKD
Volume Rata-Rata
12,09 rb
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 147,36 M | -5,19% |
Biaya operasional | 6,78 M | 4,18% |
Laba bersih | 1,85 M | -26,34% |
Margin laba bersih | 1,26 | -22,22% |
Penghasilan per saham | — | — |
EBITDA | 4,76 M | -25,05% |
Tarif pajak efektif | 22,34% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 43,33 M | 26,05% |
Total aset | 429,58 M | 2,85% |
Total liabilitas | 307,15 M | 0,84% |
Total ekuitas | 122,43 M | — |
Saham yang beredar | 3,12 M | — |
Harga terhadap nilai buku | 0,52 | — |
Tingkat pengembalian aset | 2,44% | — |
Tingkat pengembalian modal | 4,69% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 1,85 M | -26,34% |
Kas dari operasi | -20,50 M | -678,47% |
Kas dari investasi | -519,26 jt | -167,92% |
Kas dari pembiayaan | 10,78 M | 5.713,58% |
Perubahan kas bersih | -10,24 M | -512,13% |
Arus kas bebas | 2,71 M | 108,45% |
Tentang
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Didirikan
2003
Situs
Karyawan
113.635
